The HDL receptor SR-BI is associated with human prostate cancer progression and plays a possible role in establishing androgen independence
Crossref DOI link: https://doi.org/10.1186/s12958-015-0087-z
Published Online: 2015-08-07
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schörghofer, David
Kinslechner, Katharina
Preitschopf, Andrea
Schütz, Birgit
Röhrl, Clemens
Hengstschläger, Markus
Stangl, Herbert
Mikula, Mario
Funding for this research was provided by:
Austrian Science Fund (P25336-B13)
Austrian Science Fund (P25763-B13)